This is an Double Blind, Vehicle Controlled Phase 3 Study of an Investigational Medicine for Molluscum Patients Ages 6 Months and Older.


Clinical Trial for Migraine in Children

Clinical Trial for Topical Treatment of Molluscum Contagiosum

Study Location(s): Owensboro and Bowling Green Kentucky, Evansville Indiana

Molluscum contagiosum is a highly contagious viral skin infection. Infection spreads easily by person-to-person contact. The infection causes round, flesh-colored, painless bumps on the skin, which vary in size. Molluscum contagiosum can resolves on its own given enough time. Although there are over-the-counter treatments, the FDA has approved none of them.  Do to the high rate of person to person infection, a safe and effective therapy would be advantageous. This is a double-blind, vehicle-controlled, phase 3 study of an investigational medicine for patients with Molluscum contagiosum ages 6 months and older (infants, children, adolescents and adults).  This is a 24 week study. Sibling groups can participate.

There is no cost to participate.  Volunteers receive free investigational medicine and follow-up care.  No insurance needed.  Time and travel reimbursement up to $645 may be available.

Why are we asking for this information?

Baby’s due date/Birthday helps us ensure the diapers go to their intended recipients, expecting parents and newborns.  By registering for this giveaway you agree to let Qualmedica Reseasrch send information on infant formula and vaccine studies from time to time.  Click here for a complete listing of our privacy policy.

Pin It on Pinterest